Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.
Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.
复制标题
DOI:
10.2174/1389450123666220610171005
复制
发表时间:
2022
影响因子:
3.2
通讯作者:
Pehar, Mariana
中科院分区:
文献类型:
--
作者:
Kinscherf, Noah Alexander;Pehar, Mariana
关键词:
Activation of the receptor for advanced glycation end products (RAGE) has been shown to play an active role in the development of multiple neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and Amyotrophic Lateral Sclerosis. Although originally identified as a receptor for advanced glycation end products, RAGE is a pattern recognition receptor able to bind multiple ligands. The final outcome of RAGE signaling is defined in a context and cell type specific manner and can exert both neurotoxic and neuroprotective functions. Contributing to the complexity of the RAGE signaling network, different RAGE isoforms with distinctive signaling capabilities have been described. Moreover, multiple RAGE ligands bind other receptors and RAGE antagonism can significantly affect their signaling. Here, we discuss the outcome of cell-type specific RAGE signaling in neurodegenerative pathologies. In addition, we will review the different approaches that have been developed to target RAGE signaling and their therapeutic potential. A clear understanding of the outcome of RAGE signaling in a cell type- and disease-specific manner would contribute to advance the development of new therapies targeting RAGE. The ability to counteract RAGE neurotoxic signaling while preserving its neuroprotective effects would be critical for the success of novel therapies targeting RAGE signaling. This review examines the beneficial and detrimental effects of RAGE signaling in neurodegenerative conditions. Several methods have been developed to target RAGE signaling with therapeutic purposes. Strategies to specifically counteract RAGE signaling-detrimental effects while preserving its potential beneficial effects would be needed to harness their therapeutic potential.
登录
查看更多内容
影响因子:
3.3
作者:
Daborg, Jonny;von Otter, Malin;Sjolander, Annica;Nilsson, Staffan;Minthon, Lennart;Gustafson, Deborah R.;Skoog, Ingmar;Blennow, Kaj;Zetterberg, Henrik
通讯作者:
Zetterberg, Henrik
DOI:
10.1097/01.jnen.0000179050.54522.5a
发表时间:
2005-09-01
影响因子:
3.2
作者:
Dalfó, E;Portero-Otín, M;Ferrer, I
通讯作者:
Ferrer, I
影响因子:
82.9
作者:
Deane, R;Yan, SD;Zlokovic, B
通讯作者:
Zlokovic, B
影响因子:
3.7
作者:
C RC;Lukose B;Rani P
通讯作者:
Rani P
影响因子:
3.7
作者:
Di Maggio, Stefania;Gatti, Elena;Raucci, Angela
通讯作者:
Raucci, Angela